Related references
Note: Only part of the references are listed.Prognostic and Predictive Value of Intact and Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Metastatic Prostate Cancer
Charlotte E. Almasi et al.
PROSTATE (2011)
High-mobility group box 1 and cancer
Daolin Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma
Xingjun Yao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Analysis of Nuclear High Mobility Group Box 1 (HMGB1)-Binding Proteins in Colon Cancer Cells: Clustering with Proteins Involved in Secretion and Extranuclear Function
Hanna Lee et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Molecular circuits of solid tumors: prognostic and predictive tools for bedside use
Charles Ferte et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China
Ling Zhang et al.
ASIAN JOURNAL OF ANDROLOGY (2009)
Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin
Ashok Sharma et al.
CANCER INVESTIGATION (2008)
Inflammation and prostate cancer: A future target for prevention and therapy?
David Stock et al.
UROLOGIC CLINICS OF NORTH AMERICA (2008)
Inflammation and chronic prostatic diseases: Evidence for a link?
Alessandro Sciarra et al.
EUROPEAN UROLOGY (2007)
Masquerader: High mobility group box-1 and cancer
Jessica E. Ellerman et al.
CLINICAL CANCER RESEARCH (2007)
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian et al.
NATURE IMMUNOLOGY (2007)
High-mobility group box 1 (HMGB1) protein: Friend and foe
Luis Ulloa et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Characterization of biochemical recurrence after radical prostatectomy
Joseph Molitierno et al.
UROLOGIA INTERNATIONALIS (2006)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development
H Ishiguro et al.
PROSTATE (2005)
Radical prostatectomy versus watchful waiting in early prostate cancer
A Bill-Axelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer
LT Soumaoro et al.
CLINICAL CANCER RESEARCH (2004)
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
T Bonaldi et al.
EMBO JOURNAL (2003)
Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression
H Uramoto et al.
BIOCHEMICAL JOURNAL (2003)
Activation of gene expression in human neutrophils by high mobility group box 1 protein
JS Park et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
HMGB1 and HMGB2 cell-specifically down-regulate the p53-and p73-dependent sequence-specific transactivation from the human Bax gene promoter
M Stros et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
